Viewing Study NCT00636168


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2025-12-27 @ 2:14 AM
Study NCT ID: NCT00636168
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 2008-03-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
Sponsor: Bristol-Myers Squibb
Organization: